Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Grand View Research | PRODUCT CODE: 1869712

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1869712

Carrier Screening Market Size, Share & Trends Analysis Report By Medical Conditions, By Type, By Technology, By End-use, By Region, And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Carrier Screening Market Summary

The global carrier screening market size was estimated at USD 1,532.24 million in 2024 and is projected to reach USD 4,045.29 million by 2033, growing at a CAGR of 11.95% from 2025 to 2033. The rising prevalence of genetic disorders, technological advancements in genetic testing, growing awareness, and demand for personalized medicine are major factors driving the market's growth.

For instance, according to the World Health Organization, around 10 in every 1,000 individuals are affected by rare single-gene disorders, translating to between 70 million and 80 million people worldwide living with such conditions. Sickle cell disease (SCD) alone impacts more than 100,000 people in the U.S., with a particularly high prevalence among people of African American origin.

The growing technological advancement in screening techniques, particularly in next-generation sequencing (NGS) and bioinformatics, has transformed the carrier screening market by improving accuracy, speed, and affordability. Traditional genetic screening tests typically focused on a limited set of conditions, targeting specific populations or high-risk groups. In contrast, modern NGS-based panels screen hundreds of genetic mutations in a single run, providing a much broader and more comprehensive assessment. For instance, in February 2025, F. Hoffmann-La Roche AG (Switzerland) introduced a new category of next-generation sequencing by expansion (SBX) technology, which is playing a vital role in decoding complex diseases like cancer, immune disorders and neurodegenerative conditions. This technology uses high throughput sensor module along with synthetic molecules in order to determine the DNA sequence of a target molecule.

Moreover, the expansion of the carrier screening industry is propelled by rising awareness of genetic risks and the global shift toward personalized medicine. Individuals and couples are becoming increasingly proactive in managing reproductive health, seeking genetic counseling along with screening. This reflects a growing understanding that carrier status has direct implications for family planning, pregnancy outcomes, and the health of future generations.

The foundation of carrier screening lies in raising awareness to improve health outcomes through early detection programs. Early programs such as Tay-Sachs disease screening in Ashkenazi Jewish communities demonstrated how education and testing could drastically reduce disease prevalence. Similarly, community-driven sickle cell screening efforts in African American populations underscored the importance of proactive engagement, though later government-led initiatives revealed the risks of poor implementation and misinformation. These historical lessons emphasize a broader trend toward personalized medicine, where individuals and communities increasingly seek genetic insights to make informed reproductive and healthcare decisions.

However, one of the major challenges in the market emerges as traditional short-read NGS struggles with complex regions of the genome, including repeat expansions, structural variants, methylation signatures, and high-homology genes. To address these gaps, innovations such as highly accurate long-read sequencing, including HiFi technologies, are emerging. For instance, in September 2025, PacBio launched its expanded PureTarget portfolio for high-throughput carrier screening, powered by HiFi sequencing technology. The solutions streamline workflows by consolidating multiple assays into a single scalable test, enabling accurate analysis of challenging genes.

Global Carrier Screening Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global carrier screening market report based on medical conditions, type, technology, end-use, and region:

  • Medical Conditions Outlook (Revenue, USD Million, 2021 - 2033)
  • Spinal Muscular Atrophy
  • Cystic Fibrosis
  • Tay-Sachs
  • Gaucher Disease
  • Sickle Cell Disease
  • Others
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Expanded Carrier Screening
  • Targeted Disease Carrier Screening
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • DNA Sequencing
  • Polymerase Chain Reaction
  • Microarrays
  • Other Technologies (MLPA, Genotyping, Enzyme Screening)
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Laboratories
  • Physician Offices & Clinics
  • Other End Users
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68040-016-9

Table of Contents

Chapter 1. Carrier Screening Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Medical Conditions
      • 1.1.1.2. Type Segment
      • 1.1.1.3. Technology Segment
      • 1.1.1.4. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Carrier Screening Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Medical Conditions
  • 2.3. Type Snapshot
  • 2.4. Technology Snapshot
  • 2.5. End use Snapshot
  • 2.6. Competitive Landscape Snapshot

Chapter 3. Carrier Screening Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising prevalence of genetic disorders
    • 3.4.2. Technological advancements in genetic testing
    • 3.4.3. Growing awareness and demand for personalized medicine
  • 3.5. Market Restraint Analysis
    • 3.5.1. Limited implementation of public health screening
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Carrier Screening Market: Medical Conditions Estimates & Trend Analysis

  • 4.1. Carrier Screening Market: Medical Conditions Movement Analysis
  • 4.2. Spinal Muscular Atrophy
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Cystic Fibrosis
    • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Tay-Sachs
    • 4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Gaucher Disease
    • 4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Sickle Cell Disease
    • 4.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Carrier Screening Market: Type Estimates & Trend Analysis

  • 5.1. Carrier Screening Market: Type Movement Analysis
  • 5.2. Expanded Carrier Screening
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Targeted Disease Carrier Screening
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Carrier Screening Market: Technology Estimates & Trend Analysis

  • 6.1. Carrier Screening Market: End Use Movement Analysis
  • 6.2. DNA Sequencing
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Polymerase Chain Reaction
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Microarrays
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Other Technologies (MLPA, Genotyping, Enzyme Screening)
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Carrier Screening Market: End Use Estimates & Trend Analysis

  • 7.1. Carrier Screening Market: End Use Movement Analysis
  • 7.2. Hospitals
    • 7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3. Laboratories
    • 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Physician Offices & Clinics
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Other End Users
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Carrier Screening Market: Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America Carrier Screening Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Reimbursement Scenario
      • 8.2.2.5. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Reimbursement Scenario
      • 8.2.3.5. Competitive Scenario
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.2.4.2. Key Country Dynamics
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Reimbursement Scenario
      • 8.2.4.5. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe Carrier Screening Market, 2021 - 2033 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. Competitive Scenario
    • 8.3.3. Germany
      • 8.3.3.1. Germany Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Competitive Scenario
    • 8.3.4. Spain
      • 8.3.4.1. Spain Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Competitive Scenario
    • 8.3.5. France
      • 8.3.5.1. France Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Reimbursement Scenario
      • 8.3.5.5. Competitive Scenario
    • 8.3.6. Italy
      • 8.3.6.1. Italy Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Reimbursement Scenario
      • 8.3.6.5. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Reimbursement Scenario
      • 8.3.7.5. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Reimbursement Scenario
      • 8.3.8.5. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Reimbursement Scenario
      • 8.3.9.5. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia-Pacific Carrier Screening Market, 2021 - 2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Competitive Scenario
    • 8.4.6. Thailand
      • 8.4.6.1. Thailand Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Competitive Scenario
    • 8.4.7. Australia
      • 8.4.7.1. Australia Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Reimbursement Scenario
      • 8.4.7.5. Competitive Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America Carrier Screening Market, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.5.2.2. Key Country Dynamics
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Competitive Scenario
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.5.3.2. Key Country Dynamics
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. Competitive Scenario
  • 8.6. Middle East & Africa
    • 8.6.1. Middle East & Africa Carrier Screening Market, 2021 - 2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Scenario
      • 8.6.4.5. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Scenario
      • 8.6.5.5. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. NEW PRODUCT LAUNCH
    • 9.2.2. PARTNERSHIPS
    • 9.2.3. ACQUISITION
    • 9.2.4. COLLABORATION
    • 9.2.5. FUNDING
  • 9.3. Key Company Market Share Analysis, 2024
  • 9.4. Company Heat Map Analysis
  • 9.5. Company Profiles
    • 9.5.1. Myriad Genetics, Inc.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. BGI Genomics
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Illumina, Inc.
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. Thermo Fisher Scientific, Inc
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. F. Hoffmann-La Roche Ltd
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Laboratory Corporation of America Holdings (LabCorp)
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Otogenetics Corporation
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. MedGenome
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. GeneTech (ATS Genetech Pvt Ltd)
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. CENTOGENE GmbH
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives
Show more
Product Code: GVR-4-68040-016-9

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 Global Carrier Screening Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 5 Global Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 6 Global Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 7 Global Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 8 North America Carrier Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 10 North America Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 11 North America Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 12 North America Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 14 U.S. Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 15 U.S. Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 16 U.S. Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 18 Canada Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 19 Canada Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 20 Canada Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 22 Mexico Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 23 Mexico Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 24 Mexico Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe Carrier Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 26 Europe Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 27 Europe Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 28 Europe Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 29 Europe Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 UK Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 31 UK Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 32 UK Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 33 UK Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Germany Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 35 Germany Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 36 Germany Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 37 Germany Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 France Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 39 France Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 40 France Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 41 France Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 43 Italy Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 44 Italy Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 45 Italy Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 47 Spain Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 48 Spain Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 49 Spain Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 50 Sweden Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 51 Sweden Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 52 Sweden Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 53 Sweden Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Norway Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 55 Norway Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 56 Norway Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 57 Norway Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 Denmark Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 59 Denmark Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 60 Denmark Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 61 Denmark Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Carrier Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 65 Asia-Pacific Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Japan Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 68 Japan Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 69 Japan Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 70 Japan Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71 China Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 72 China Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 73 China Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 74 China Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75 India Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 76 India Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 77 India Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 78 India Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 Australia Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 80 Australia Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 81 Australia Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 82 Australia Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 Thailand Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 84 Thailand Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 85 Thailand Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 86 Thailand Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 South Korea Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 88 South Korea Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 89 South Korea Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 90 South Korea Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America Carrier Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 92 Latin America Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 93 Latin America Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 94 Latin America Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 95 Latin America Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 97 Brazil Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 98 Brazil Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 99 Brazil Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 101 Argentina Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 102 Argentina Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 103 Argentina Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 104 MIDDLE EAST & AFRICA Carrier Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 105 MIDDLE EAST & AFRICA Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 106 MIDDLE EAST & AFRICA Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 107 MIDDLE EAST & AFRICA Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 108 Middle East & Africa Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 110 South Africa Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 111 South Africa Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 112 South Africa Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 117 UAE Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 118 UAE Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 119 UAE Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 120 UAE Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Carrier Screening Market, By End Use, 32021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global carrier screening market- Key market driver analysis
  • Fig. 7 Global carrier screening market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global carrier screening market - Porter's analysis
  • Fig. 10 Global carrier screening market - PESTEL analysis
  • Fig. 11 Global carrier screening market Medical Conditions outlook key takeaways
  • Fig. 12 Global carrier screening market: Medical Conditions movement analysis
  • Fig. 13 Spinal muscular Atrophy market estimates, 2021 - 2033 (USD Million)
  • Fig. 14 Cystic fibrosis market estimates, 2021 - 2033 (USD Million)
  • Fig. 15 Tay-Sachs market estimates, 2021 - 2033 (USD Million)
  • Fig. 16 Gaucher disease market estimates, 2021 - 2033 (USD Million)
  • Fig. 17 Sickle cell disease market estimates, 2021 - 2033 (USD Million)
  • Fig. 18 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 19 Global carrier screening market technology outlook key takeaways
  • Fig. 20 Global carrier screening market: technology movement analysis
  • Fig. 21 Expanded carrier screening market estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Targeted disease carrier screening market estimates, 2021 - 2033 (USD Million)
  • Fig. 23 Global carrier screening market technology outlook key takeaways
  • Fig. 24 Global carrier screening market technology movement analysis
  • Fig. 25 DNA sequencing market estimates, 2021 - 2033 (USD Million)
  • Fig. 26 Polymerase chain reaction market estimates, 2021 - 2033 (USD Million)
  • Fig. 27 Microarrays market estimates, 2021 - 2033 (USD Million)
  • Fig. 28 Other technologies (MLPA, genotyping, enzyme screening) market estimates, 2021 - 2033 (USD Million)
  • Fig. 29 Global carrier screening market end use outlook key takeaways
  • Fig. 30 Global carrier screening market end use movement analysis
  • Fig. 31 Hospitals market estimates, 2021 - 2033 (USD Million)
  • Fig. 32 Laboratories market estimates, 2021 - 2033 (USD Million)
  • Fig. 33 Physician offices & clinics market estimates, 2021 - 2033 (USD Million)
  • Fig. 34 Other end users market estimates, 2021 - 2033 (USD Million)
  • Fig. 35 Regional marketplace: Key takeaways
  • Fig. 36 Global Carrier Screening Market: Regional movement analysis
  • Fig. 37 North America Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 39 Canada Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 40 Mexico Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 41 Europe Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 42 UK Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 43 Germany Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 44 France Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 45 Spain Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 46 Italy Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 47 Denmark Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 48 Sweden Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 49 Norway Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 50 Asia Pacific Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 51 Japan Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 52 China Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 53 India Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 54 South Korea Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 55 Australia Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 56 Thailand Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 57 Latin America Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 58 Brazil Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 59 Argentina Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 60 Middle East & Africa Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 61 South Africa Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 62 Saudi Arabia Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 63 UAE Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 64 Kuwait Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 65 Strategy framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!